share_log

Recursion Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Marriott Tina

SEC ·  Jul 30 06:20
Summary by Futu AI
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on July 25, 2024. The transaction was executed at a price of $8.1349 per share, resulting in a total market value of $48,809.40. Prior to this sale, Marriott exercised an equivalent number of shares at a price of $1.06 each. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 535,457 shares.
Tina Marriott, President and COO of Recursion Pharmaceuticals, completed a sale of 6,000 shares of the company's Class A Common Stock on July 25, 2024. The transaction was executed at a price of $8.1349 per share, resulting in a total market value of $48,809.40. Prior to this sale, Marriott exercised an equivalent number of shares at a price of $1.06 each. Following the transactions, Marriott's direct holdings in Recursion Pharmaceuticals amount to 535,457 shares.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.